US Broker Ratings

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 27% Upside Potential with Robust Growth Prospects

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, is capturing investor attention with a promising upside potential of 27.42%. Headquartered in Dublin,..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a 42.11% Upside Potential with a Strong Buy Consensus

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands out in the biotechnology sector, capturing investor attention with its focus on rare neuroendocrine diseases. Headquartered in Boston, Massachusetts, this..

Halozyme Therapeutics (HALO) Stock Analysis: Strong Revenue Growth and Significant Upside Potential

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, has captured investor attention with its innovative approach to drug delivery and impressive financial..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a 16.4% Potential Upside Amidst Market Volatility

Oscar Health, Inc. (NYSE: OSCR), a healthcare technology company, presents a compelling opportunity for investors who are keen to explore the evolving landscape of healthcare plans..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unveiling a 73% Potential Upside in the Healthcare Sector

For investors with an eye for opportunity in the healthcare sector, Stevanato Group S.p.A. (NYSE: STVN) presents a compelling case. Headquartered in Italy, this company operates..

Henry Schein, Inc. (HSIC) Stock Analysis: A Comprehensive Look at Growth Potential Amidst Healthcare Distribution Dynamics

Henry Schein, Inc. (NASDAQ: HSIC), a prominent player in the medical distribution sector, has carved out a significant niche by providing a wide array of healthcare..

Globus Medical, Inc. (GMED): Investor Outlook and Growth Potential Amid Strong Analyst Consensus

Globus Medical, Inc. (NYSE: GMED), a prominent player in the healthcare sector, is making waves in the medical devices industry with its innovative solutions for musculoskeletal..

Krystal Biotech, Inc. (KRYS) Stock Analysis: An Investor’s Guide to a Promising 17% Upside

Krystal Biotech, Inc. (NASDAQ: KRYS), a dynamic player in the biotechnology sector, presents an intriguing opportunity for investors seeking exposure to the healthcare market’s innovative edge...

Telix Pharmaceuticals Limited (TLX) Stock Report: Unpacking a 183.83% Upside Potential

Telix Pharmaceuticals Limited (ASX: TLX), an innovative player in the biotechnology sector, is captivating investor attention with its robust pipeline of diagnostic and therapeutic radiopharmaceuticals. Headquartered..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 19.42% Potential Upside in the Healthcare Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a stalwart in the healthcare sector, is making waves in the investor community with a promising potential upside of 19.42%. With..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating the Volatility in a $14.42 Billion Healthcare Innovator

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based Traditional Chinese Medicine (TCM) bioscience company, stands at the intersection of healthcare innovation and market volatility. With..

Integer Holdings Corporation (ITGR) Stock Analysis: Uncovering an 8% Potential Upside in the Medical Devices Sector

As investors navigate the dynamic landscape of the healthcare sector, Integer Holdings Corporation (NYSE: ITGR) emerges as a noteworthy player in the medical devices industry. With..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Healthcare Innovator with a 7.41% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX), a pioneering player in the healthcare sector, is redefining the organ transplant landscape with its groundbreaking Organ Care System (OCS). This..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Navigating Growth in the Eye Health Sector

Bausch + Lomb Corporation (NYSE: BLCO) is a stalwart in the healthcare sector, specifically in medical instruments and supplies, with a rich history dating back to..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A Robust 18% Potential Upside

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands out as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a 3.95% Potential Upside in the Medical Devices Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the healthcare sector specializing in medical devices, continues to attract investor attention with its robust market..

BridgeBio Pharma (BBIO) Investor Outlook: Exploring a 44% Upside Potential Amidst Biotech Innovations

BridgeBio Pharma, Inc. (NASDAQ: BBIO) has captured the attention of investors with its robust pipeline of transformative medicines targeting genetic diseases and cancers. With a market..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Biotech Contender with 184% Upside Potential

Investors in the healthcare sector might want to keep a close eye on Soleno Therapeutics, Inc. (NASDAQ: SLNO), a biotechnology company whose stock currently presents a..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating Growth Amidst Market Challenges

Molina Healthcare Inc (MOH), a leader in the healthcare plans industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. Based in Long..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring a 41% Upside Potential in the Healthcare Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC), a pioneering player in the medical devices industry, has been making waves with its innovative solutions in digital healthcare. Headquartered in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds